can i inject ghk cu GHK-CU GHK-Cu Copper Peptide Injections: Advanced

Weight Management Program

Extended stability beyond 2 years

The cardiovascular outcomes endpoint (REDEFINE 3) is event-driven and has not yet reported

A key finding was its ability to reduce phosphorylation of myosin light chain-2 through inhibition of the ROCK pathway, a central regulator of perijunctional actomyosin contraction and barrier leakiness

Its molecular target is nicotinamide N-methyltransferase (NNMT), a cytosolic S-adenosyl-L-methionine-dependent methyltransferase that converts nicotinamide to 1-methylnicotinamide, consuming SAM and releasing S-adenosylhomocysteine

At worst, it could produce unintended and adverse effects